Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Tools Developed for Early Meningitis Diagnosis

By LabMedica International staff writers
Posted on 28 Sep 2010
A predictive model based on two blood tests and a clinical sign will allow physicians assess whether or not a suspected case of meningitis is bacterial or viral in origin. More...


Bacterial meningitis is a serious infection of the fluid in the spinal cord and the fluid that surrounds the brain commonly caused by three types of bacteria: Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae bacteria. The diagnosis is usually made by growing the bacteria in culture from cerebral spinal fluid obtained from a lumbar puncture.

In a recent report from the UK Health Protection Agency's (HPA; London, UK) annual conference, analysis of data collected on 720 patients from all probable cases of bacterial and viral meningitis was presented. The patients had been admitted to participating hospitals in the South West, West Midlands and London regions of England. The date was collected from July 1, 2008 and June 30, 2009.

After examining the clinical symptoms, biochemistry and microbiology of 385 confirmed cases of meningitis over a 12 month period, the team identified three factors based on routine clinical assessment and early available laboratory test results that help differentiate between bacterial and viral meningitis. The results showed that the peripheral polymorphonuclear leukocyte (PMN) count, C-reactive protein level in the blood and rash are strongly associated with bacterial meningitis. Leukocyte PMN counts above 16 × 109/L, and a C-reactive protein level of more than 100 mg/L associated with a hemorrhagic rash, were most likely to be found in confirmed cases of bacterial meningitis. The normal PMN count varies with age, but the range is usually between 2.5 × 109/L to 7.5 × 109/L and a normal C-reactive protein is less than 10mg/L.

Oluwatoyin O. Ejidokun M.B. B.S., M.Sc., Ph.D.,, who led the study team, said, "While further testing needs to take place to test the accuracy of the model, this simple model offers the prospect of a rapid predictive tool to help clinical and public health management of suspected bacterial meningitis cases." Swift diagnosis of bacterial meningitis is crucial to protecting public health as it means potentially lifesaving interventions can be put in places, such as prescribing antibiotics to the patient and people they have been in contact with.
Related Links:
UK Health Protection Agency




Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.